Diallyl trisulfide inhibits estrogen receptor-α activity in human breast cancer cells

Breast Cancer Research and Treatment

Volumn 144, Issue 1, 2014, Pages 47-57

  Hahm, Eun Ryeong ^a   Singh, Shivendra V ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; Chemoprevention; Diallyl trisulfide; Estrogen receptor

Indexed keywords

ALLYL SULFIDE; CYCLIN D1; DIALLYL DISULFIDE; DIALLYL TRISULFIDE; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; LUCIFERASE; PEPTIDYLPROLYL ISOMERASE PIN1; PROTEIN ERE2E1B; PROTEIN PS2; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CANCER INHIBITION; CELL LEVEL; CELL PROLIFERATION; CELL PROTECTION; CELL STRAIN MCF 7; CELL STRAIN T47D; CELL VIABILITY; ENZYME ACTIVITY; ENZYME INHIBITION; GENE PRODUCT; GENE REPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS INHIBITION; RECEPTOR DOWN REGULATION;

ALLYL COMPOUNDS; ANTIOXIDANTS; APOPTOSIS; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DISULFIDES; DOWN-REGULATION; ESTROGEN RECEPTOR ALPHA; HUMANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84894658224     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-014-2841-x     Document Type: Article

References (39)

1. Rivlin RS (2001) Historical perspective on the use of garlic. J Nutr 131(3):951S-954S
2. Rahman K (2001) Historical perspective on garlic and cardiovascular disease. J Nutr 131(3):977S-979S
3. Dausch JG, Nixon DW (1990) Garlic: a review of its relationship to malignant disease. Prev Med 19(3):346-361
4. Agarwal KC (1996) Therapeutic actions of garlic constituents. Med Res Rev 16(1):111-124
5. El-Bayoumy K, Sinha R, Pinto JT, Rivlin RS (2006) Cancer chemoprevention by garlic and garlic-containing sulfur and selenium compounds. J Nutr 136(3):864S-869S
6. Block E (1992) The organosulfur chemistry of the genus Allium: implications for the organic chemistry of sulfur. Angew Chem Int Ed Engl 31(9):1135-1178
7. You WC, Blot WJ, Chang YS, Ershow A, Yang ZT, An Q, Henderson BE, Fraumeni JF Jr, Wang TG (1989) Allium vegetables and reduced risk of stomach cancer. J Natl Cancer Inst 81(2):162-164
8. Dorant E, van den Brandt PA, Goldbohm RA (1995) Allium vegetable consumption, garlic supplement intake, and female breast carcinoma incidence. Breast Cancer Res Treat 33(2):163-170
9. Challier B, Perarnau JM, Viel JF (1998) Garlic, onion and cereal fiber as protective factors for breast cancer: a French case-control study. Eur J Epidemiol 14(8):737-747
10. Fleischauer AT, Poole C, Arab L (2000) Garlic consumption and cancer prevention: meta-analyses of colorectal and stomach cancers. Am J Clin Nutr 72(4):1047-1052
11. Herman-Antosiewicz A, Powolny AA, Singh SV (2007) Molecular targets of cancer chemoprevention by garlic-derived organosulfides. Acta Pharmacol Sin 28(9):1355-1364
12. Antony ML, Singh SV (2011) Molecular mechanisms and targets of cancer chemoprevention by garlic-derived bioactive compound diallyl trisulfide. Ind J Exp Biol 49(11):805-816
13. Xiao D, Choi S, Johnson DE, Vogel VG, Johnson CS, Trump DL, Lee YJ, Singh SV (2004) Diallyl trisulfide-induced apoptosis in human prostate cancer cells involves c-Jun N-terminal kinase and extracellular-signal regulated kinase-mediated phosphorylation of Bcl-2. Oncogene 23(33):5594-5606
14. Na HK, Kim EH, Choi MA, Park JM, Kim DH, Surh YJ (2012) Diallyl trisulfide induces apoptosis in human breast cancer cells through ROS-mediated activation of JNK and AP-1. Biochem Pharmacol 84(10):1241-1250
15. Hu X, Benson PJ, Srivastava SK, Xia H, Bleicher RJ, Zaren HA, Awasthi S, Awasthi YC, Singh SV (1997) Induction of glutathione S-transferase π as a bioassay for the evaluation of potency of inhibitors of benzo(a)pyrene-induced cancer in a murine model. Int J Cancer 73(6):897-902
16. Xiao D, Lew KL, Kim YA, Zeng Y, Hahm ER, Dhir R, Singh SV (2006) Diallyl trisulfide suppresses growth of PC-3 human prostate cancer xenograft in vivo in association with Bax and Bak induction. Clin Cancer Res 12(22):6836-6843
17. Singh SV, Powolny AA, Stan SD, Xiao D, Arlotti JA, Warin R, Hahm ER, Marynowski SW, Bommareddy A, Potter DM, Dhir R (2008) Garlic constituent diallyl trisulfide prevents development of poorly differentiated prostate cancer and pulmonary metastasis multiplicity in TRAMP mice. Cancer Res 68(22):9503-9511
18. Malki A, El-Saadani M, Sultan AS (2009) Garlic constituent diallyl trisulfide induced apoptosis in MCF7 human breast cancer cells. Cancer Biol Ther 8(22):2175-2185
19. Nkrumah-Elie YM, Reuben JS, Hudson A, Taka E, Badisa R, Ardley T, Israel B, Sadrud-Din SY, Oriaku E, Darling-Reed SF (2012) Diallyl trisulfide as an inhibitor of benzo(a)pyrene-induced precancerous carcinogenesis in MCF-10A cells. Food Chem Toxicol 50(7):2524-2530
20. Chandra-Kuntal K, Lee J, Singh SV (2013) Critical role for reactive oxygen species in apoptosis induction and cell migration inhibition by diallyl trisulfide, a cancer chemopreventive component of garlic. Breast Cancer Res Treat 138(1):69-79
21. Hahm ER, Lee J, Huang Y, Singh SV (2011) Withaferin A suppresses estrogen receptor-α expression in human breast cancer cells. Mol Carcinog 50(8):614-624
22. Sakao K, Singh SV (2012) d,l-Sulforaphane-induced apoptosis in human breast cancer cells is regulated by the adapter protein p66Shc. J Cell Biochem 113(2):599-610
23. 2/M arrest and inducing apoptosis. Carcinogenesis 24(5):891-897
24. Shah YM, Kaul A, Dong Y, Ip C, Rowan BG (2005) Attenuation of estrogen receptor α (ERα) signaling by selenium in breast cancer cells via downregulation of ERα gene expression. Breast Cancer Res Treat 92(3):239-250
25. Lee BC, Park BH, Kim SY, Lee YJ (2011) Role of Bim in diallyl trisulfide-induced cytotoxicity in human cancer cells. J Cell Biochem 112(1):118-127
26. Sui M, Huang Y, Park BH, Davidson NE, Fan W (2007) Estrogen receptor α mediates breast cancer cell resistance to paclitaxel through inhibition of apoptotic cell death. Cancer Res 67(11):5337-5344
27. Rajbhandari P, Finn G, Solodin NM, Singarapu KK, Sahu SC, Markley JL, Kadunc KJ, Ellison-Zelski SJ, Kariagina A, Haslam SZ, Lu KP, Alarid ET (2012) Regulation of estrogen receptor α N-terminus conformation and function by peptidyl-prolyl isomerase Pin1. Mol Cell Biol 32(2):445-457
28. Rajbhandari P, Schalper KA, Solodin NM, Ellison-Zelski SJ, Ping LK, Rimm DL, Alarid ET (2013) Pin1 modulates ERα levels in breast cancer through inhibition of phosphorylation-dependent ubiquitination and degradation. Oncogene. doi: 10.1038/onc.2013.78
29. Lucchetti C, Caligiuri I, Toffoli G, Giordano A, Rizzolio F (2013) The prolyl isomerase Pin1 acts synergistically with CDK2 to regulate the basal activity of estrogen receptor α in breast cancer. PLoS ONE 8(2):e55355
30. Lee TH, Pastorino L, Lu KP (2011) Peptidyl-prolyl cis-trans isomerase Pin1 in ageing, cancer and Alzheimer disease. Expert Rev Mol Med 13:e21
31. Spears M, Bartlett J (2009) The potential role of estrogen receptors and the SRC family as targets for the treatment of breast cancer. Expert Opin Ther Targets 13(6):665-674
32. Welboren WJ, Sweep FC, Span PN, Stunnenberg HG (2009) Genomic actions of estrogen receptor α: what are the targets and how are they regulated? Endocr Relat Cancer 16(4):1073-1089
33. Fisher B, Costantino JP, Wickerham DL, Redmond CK, Kavanah M, Cronin WM, Vogel V, Robidoux A, Dimitrov N, Atkins J, Daly M, Wieand S, Tan-Chiu E, Ford L, Wolmark N (1998) Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 90(18):1371-1388
34. Obiorah I, Jordan VC (2011) Progress in endocrine approaches to the treatment and prevention of breast cancer. Maturitas 70(4):315-321
35. Sun X, Guo T, He J, Zhao M, Yan M, Cui F, Deng Y (2006) Determination of the concentration of diallyl trisulfide in rat whole blood using gas chromatography with electron-capture detection and identification of its major metabolite with gas chromatography mass spectrometry. Yakugaku Zasshi 126(7):521-527
36. Li H, Li HQ, Wang Y, Xu HX, Fan WT, Wang ML, Sun PH, Xie XY (2004) An intervention study to prevent gastric cancer by micro-selenium and large dose of allitridum. Chin Med J 117(8):1155-1160
37. Frasor J, Danes JM, Komm B, Chang KC, Lyttle CR, Katzenellenbogen BS (2003) Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype. Endocrinology 144(10):4562-4574
38. Kim MR, Choi HK, Cho KB, Kim HS, Kang KW (2009) Involvement of Pin1 induction in epithelial-mesenchymal transition of tamoxifen-resistant breast cancer cells. Cancer Sci 100(10):1834-1841
39. Cauley JA, Norton L, Lippman ME, Eckert S, Krueger KA, Purdie DW, Farrerons J, Karasik A, Mellstrom D, Ng KW, Stepan JJ, Powles TJ, Morrow M, Costa A, Silfen SL, Walls EL, Schmitt H, Muchmore DB, Jordan VC, Ste-Marie LG (2001) Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial: multiple Outcomes of Raloxifene Evaluation. Breast Cancer Res Treat 65(2):125-134